Showing 4741-4750 of 5957 results for "".
- Reed Exhibitions Unveils New Brand Identityhttps://modernod.com/news/reed-exhibitions-unveils-new-brand-identity/2479287/Reed Exhibitions announced its evolution to RX, with a refreshed visual identity and updated brand positioning, according to The Vision Council. Building on its flagship events business, the company is leveraging its capabilities in data and technology to create
- Iveric Bio to Host Investor Symposium on Dry AMDhttps://modernod.com/news/iveric-bio-to-host-investor-symposium-on-dry-amd/2479282/Iveric bio announced details for its Dry Age-Related Macular Degeneration Virtual Symposium for investors and analysts being held on Friday, June 18, 2021 from 10 am to 12 pm Eastern Time. The symposium will include presentations on the company’s Zimura (avacincaptad pegol) pivotal program in geo
- Outlook Therapeutics Completes Patient Dosing in Phase 3 NORSE TWO Trial for Wet AMDhttps://modernod.com/news/outlook-therapeutics-completes-patient-dosing-in-phase-3-norse-two-trial-for-wet-amd/2479279/Outlook Therapeutics reported that it has administered the final dose to the last patient enrolled in its pivotal NORSE TWO safety and efficacy study evaluating ONS-5010 (bevacizumab-vikg) for treatment of wet age-related macular degeneration (AMD). Topline data are expected to be reported for NO
- EyeYon Medical Receives CE Mark for its EndoArt Implant to Treat Chronic Corneal Edemahttps://modernod.com/news/eyeyon-medical-receives-ce-mark-for-its-endoart-implant-to-treat-chronic-corneal-edema/2479277/EyeYon Medical announced that it has received CE Mark for its EndoArt after clinical trials demonstrated safety and efficacy for treating chronic corneal edema. EyeYon says the EndoArt is the world’s first and only synthetic implant that replaces the human endothelium that the human
- International Sports Vision Association and Macuhealth Offer New Educational Resource on Sports Nutrition for Your Eyeshttps://modernod.com/news/international-sports-vision-association-and-macuhealth-offer-new-educational-resource-on-sports-nutrition-for-your-eyes/2479270/The International Sports Vision Association (ISVA) and MacuHealth announced the launch of “Sports Nutrition for Your Eyes,” a new educational resource on the ISVA website designed to help educate athletes about how proper nutrition ca
- Lighthouse Guild Starts Construction on New Technology Centerhttps://modernod.com/news/lighthouse-guild-starts-construction-on-new-technology-center/2479265/Lighthouse Guild has started construction on a Technology Center that will be the largest, premier assistive technology resource in the United States, according to a news release. Designed for people who are visually impaired and for all people who are using technology in order to help them, it i
- Scientists Use Video Games to Shed Light on the Link Between Motor Activity and Visionhttps://modernod.com/news/scientists-use-video-games-to-shed-light-on-the-link-between-motor-activity-and-vision/2479266/It’s a well established fact—and intuitive truth—that vision guides movement, and that information flows readily from the visual cortex to motor centers. However, the inverse relation is far less well understood. Does engaging in movement affect how our vision is processed? Three researchers from
- VSY Biotechnology Announces Launch of the Enova C Haptic Model IOLhttps://modernod.com/news/vsy-biotechnology-announces-launch-of-the-enova-c-haptic-model-iol/2479260/VSY Biotechnology announced the launch of the Enova C Haptic Model IOL. Enova is the first and only 100% glistening-free, dry-packed hydrophobic acrylic IOL, according to VSY Biotechnology. The lens requires no warming or special conditioning before surgery. The composition of Enova mater
- Avellino Launches AvaGen as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophieshttps://modernod.com/news/avellino-launches-avagen-as-first-genetic-test-to-quantify-keratoconus-risk-and-presence-of-corneal-dystrophies/2479255/Avellino Lab USA announced full nationwide availability in the US of AvaGen, as the first genetic test that helps determine a patient’s risk of keratoconus and the presence of other corneal dystrophies. The test allows for more confident management and treatment for patients with these conditions
- Bausch Health And Clearside Biomedical Announce FDA Filing Acceptance For Xiperehttps://modernod.com/news/bausch-health-and-clearside-biomedical-announce-fda-filing-acceptance-for-xipere/2479252/Bausch Health Companies and Bausch + Lomb, along with Clearside Biomedical, announced that the FDA has accepted the resubmitted new drug application for Xipere (triamcinolone acetonide suprachoroidal injectable suspension). FDA determined that the filing is a Class 2 resubmission and therefore as